IGC Pharma, Inc. ("IGC Pharma" or the "Company") announced today that its ongoing Phase 2 trial for agitation in Alzheimer's disease has been officially named CALMA (Calming Agitation in Alzheimer's).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback